Professor Mimoun Azzouz, a distinguished Moroccan researcher, has garnered significant recognition for his groundbreaking work in the field of gene therapy. As the head of the Gene Therapy Innovation Center (GTIMC) at the University of Sheffield, located approximately 270 kilometers north of London, he has been awarded the prestigious Outstanding Achievement Award by the British Society for Gene and Cell Therapy. This accolade is a testament to his substantial contributions to both research and training in the complex domain of gene therapy, underscoring his status as a leader in this innovative field.
In addition to his role at GTIMC, Professor Azzouz is also a professor of translational neuroscience at the University of Sheffield, where he has made remarkable strides in the development of novel therapies aimed at treating neurological disorders. His research predominantly revolves around the translation of fundamental scientific discoveries into tangible treatment options, effectively bridging the gap between laboratory research and clinical trials involving human subjects.
Since 2006, Professor Azzouz has successfully raised over £34 million to support his research initiatives, leading several pioneering studies that have significantly advanced the field. Notably, his team was the first to demonstrate the effectiveness of a gene therapy targeting the SMN gene in models of spinal muscular atrophy. This groundbreaking work has paved the way for innovative clinical trials in humans and ultimately led to the approval of a treatment that has the potential to transform the lives of those affected by this condition.
In his pursuit of advancing research on neurological diseases, Professor Azzouz leads a collaborative network of 34 institutions and companies across Europe. This extensive collaboration aims to propel research in this highly specialized scientific area. Emphasizing Morocco's potential in the realm of scientific inquiry, he has committed himself to training a cohort of Moroccan researchers, furthering the goal of enhancing Morocco's contributions to scientific research and health initiatives.
Beyond his academic achievements, Professor Azzouz is also a scientific entrepreneur, having founded BlackfinBio and co-founded Crucible Therapeutics. He oversees a €25.5 million European consortium that unites 34 partners, all dedicated to accelerating the development of advanced therapeutic solutions. His mentorship has been instrumental in shaping the careers of 81 scientists, including 20 PhD students, thereby contributing to the cultivation of the next generation of researchers in the field.
The recognition from the British Society for Gene and Cell Therapy serves to highlight the illustrious career of Professor Azzouz, whose scientific and medical contributions resonate on a global scale. His work not only exemplifies the potential of Moroccan researchers but also underscores the importance of international collaboration in advancing health sciences.
As reported by en.hespress.com.
